首页> 外国专利> use of fenofibrate composition in a medicament to treat hypertriglyceridemia, hypercholesterolemia or hyperlipidemia while reducing the effect of diet on fenofibrate bioavailability

use of fenofibrate composition in a medicament to treat hypertriglyceridemia, hypercholesterolemia or hyperlipidemia while reducing the effect of diet on fenofibrate bioavailability

机译:非诺贝特组合物在药物中的用途,用于治疗高甘油三酸酯血症,高胆固醇血症或高脂血症,同时减少饮食对非诺贝特生物利用度的影响

摘要

"fenofibrate-containing pharmaceutical composition and method for preparing it". The invention relates to the use of a fenofibrate composition containing micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization aid, said composition containing an amount of fenofibrate greater than or equal to 60% by weight. for the preparation of a medicament for treating hypertriglyceridemia, hypercholesterolaemia or hyperlipidaemia while reducing the effect of diet on the bioavailability of fenofibrate. The invention is likewise related to an immediate release composition in the form of granules comprising: (a) a neutral core; (b) an active layer surrounding the core; and (c) an outer layer; wherein said active layer comprises micronized fenofibrate, a surfactant and a binding cellulose derivative; and wherein said composition has a dissolution profile of less than 10% in 5 minutes and greater than 80% in 20 minutes according to the European Pharmacopoeia in a dissolution medium consisting of water containing 0.025 m sodium lauryl sulfate. .
机译:“含非诺贝特的药物组合物及其制备方法”。本发明涉及含有微粉化非诺贝特,表面活性剂和结合纤维素衍生物的非诺贝特组合物作为增溶剂的用途,所述组合物包含大于或等于60重量%的非诺贝特。用于制备用于治疗高甘油三酸酯血症,高胆固醇血症或高脂血症的药物,同时降低饮食对非诺贝特生物利用度的影响。本发明同样涉及颗粒形式的速释组合物,其包括:(a)中性核; (b)围绕核心的有源层; (c)外层;其中所述活性层包含微粉非诺贝特,表面活性剂和结合纤维素衍生物。并且其中根据欧洲药典,所述组合物在由含有0.025m月桂基硫酸钠的水组成的溶出介质中,在5分钟内的溶出曲线在5分钟内小于10%,在20分钟内的溶出曲线大于80%。 。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号